BHF · Brighthouse Financial, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $6.77B | $4.72B | $4.12B | $8.47B | $7.14B | $8.50B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - |
| Total Operating Expenses | $1.96B | $1.95B | $1.98B | $2.08B | $2.45B | $2.35B |
| D&A | - | - | - | - | - | - |
| Operating Income | $474.00M | $422.00M | ($1.47B) | ($172.00M) | ($208.00M) | ($1.42B) |
| Interest Expense | $152.00M | $152.00M | $153.00M | $153.00M | $163.00M | $184.00M |
| Income Tax | $36.00M | $29.00M | ($367.00M) | ($182.00M) | ($105.00M) | ($363.00M) |
| Net Income | $433.00M | $388.00M | ($1.11B) | $5.00M | ($108.00M) | ($1.06B) |
| EPS - Basic | $5.75 | $4.67 | ($18.39) | ($1.36) | ($2.36) | ($11.58) |
| EPS - Diluted | $5.71 | $4.64 | ($18.39) | ($1.36) | ($2.36) | ($11.58) |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.39B | $5.04B | $3.85B | $4.12B | $4.47B | $4.11B |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - |
| Total Assets | $241.80B | $238.54B | $236.34B | $225.58B | $259.84B | $247.87B |
| Current Liabilities | - | - | - | - | - | - |
| Long-term Debt | $3.15B | $3.15B | $3.16B | $3.16B | $3.16B | $3.44B |
| Total Liabilities | $234.97B | $233.51B | $231.33B | $219.54B | $243.63B | $229.78B |
| Stockholders' Equity | $6.77B | $4.96B | $4.94B | $5.97B | $16.14B | $18.02B |
| Retained Earnings | ($686.00M) | ($1.12B) | ($1.51B) | ($637.00M) | ($642.00M) | ($534.00M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $259.00M | ($290.00M) | ($137.00M) | ($1.15B) | $746.00M | $888.00M |
| Investing Cash Flow | $751.00M | ($2.19B) | ($3.20B) | ($8.28B) | ($12.24B) | ($5.84B) |
| Financing Cash Flow | ($668.00M) | $3.68B | $3.07B | $9.07B | $11.86B | $6.19B |
| CapEx | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | 7.0% | 8.9% | -35.8% | -2.0% | -2.9% | -16.7% |
| EBITDA margin | - | - | - | - | - | - |
| Net margin | 6.4% | 8.2% | -27.0% | 0.1% | -1.5% | -12.5% |
| Free cash flow margin | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - |
| Effective tax rate | 7.7% | 7.0% | - | - | - | - |
| Return on assets | 0.2% | 0.2% | -0.5% | 0.0% | -0.0% | -0.4% |
| Return on equity | 6.4% | 7.8% | -22.5% | 0.1% | -0.7% | -5.9% |
| Return on invested capital | 4.4% | 4.8% | -14.4% | -1.5% | -0.9% | -5.2% |
| Liquidity | ||||||
| Current ratio | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - |
| Leverage | ||||||
| Debt / Equity | 0.47 | 0.64 | 0.64 | 0.53 | 0.20 | 0.19 |
| Debt / Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | 3.1x | 2.8x | -9.6x | -1.1x | -1.3x | -7.7x |
| Equity multiplier | 35.73 | 48.10 | 47.81 | 37.77 | 16.10 | 13.75 |
| Liabilities / Assets | 0.97 | 0.98 | 0.98 | 0.97 | 0.94 | 0.93 |
| Efficiency | ||||||
| Asset turnover | 0.03 | 0.02 | 0.02 | 0.04 | 0.03 | 0.03 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 11.3x | 10.4x | - | - | - | - |
| P / B | 0.6x | 0.6x | 0.7x | 0.6x | 0.3x | 0.2x |
| P / S | 0.6x | 0.6x | 0.8x | 0.4x | 0.6x | 0.4x |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 43.2% | 14.7% | -51.4% | 18.6% | -16.0% | 29.7% |
| Revenue CAGR (3y) | -7.2% | -12.9% | -21.5% | 8.9% | -7.3% | 41.2% |
| Revenue CAGR (5y) | -4.5% | -6.3% | -14.4% | 22.9% | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | 12.3% | - | -757.0% | 17.3% | 85.3% | -34.9% |
| Net income growth (YoY) | 11.6% | - | - | - | 89.8% | -43.4% |
| EPS growth (YoY) | 23.1% | - | -1252.2% | 42.4% | 79.6% | -71.3% |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | 36.5% | 0.3% | -17.2% | -63.0% | -10.4% | 11.4% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$6.77B totalAnnuities$3.64B · 53.8%
Runoff$1.27B · 18.8%
Life$1.15B · 17.0%
Corporate And Other$705.00M · 10.4%
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✗Cash flow > net income
- ✗Long-term debt decreased
- -Current ratio improved
- ✓No share dilution
- -Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Life Insurance
Comparing Brighthouse Financial against the 5 most active filers in the same SIC group.